Robert Baltera

Mr. Baltera is a seasoned biopharmaceutical executive, board director and Senior Advisor at Frazier Life Sciences, with more than three decades of experience spanning company leadership, corporate strategy, product development, operations, manufacturing, commercial planning and strategic transactions. He has served as Chief Executive Officer and Board Director of Cirius Therapeutics and currently serves on the Board of Directors of Inipharm. Previously, Mr. Baltera served as Chief Executive Officer of Amira Pharmaceuticals, where he helped advance the company’s pipeline and strategic collaborations prior to its sale to Bristol-Myers Squibb in 2011 for $475 million. He also previously served as Chairman of Mavupharma until its acquisition by AbbVie and served on the boards of Frazier Lifesciences Acquisition Corporation and Imago BioSciences, which was acquired by Merck. Earlier in his career, Mr. Baltera held several senior management positions during a 17-year tenure at Amgen. He brings deep expertise in guiding emerging life sciences companies through company formation, clinical development, operational execution, corporate development, financing and strategic transactions.